| 
                    Title
                 | 
                
                    Journal
                 | 
                
                    Year
                 | 
                 | 
            
            
                    
                        
                            
                                Discovery of diverse and functional antibodies from large human repertoire antibody libraries.
                             
                            
                         | 
                        
                            
                                
                         | 
                        
                            
                         | 
                        
                            
                                 
                            
                         | 
                    
                
                    
                        
                            
                                Dual blockade of the PI3K/AKT/mTOR (AZD8055) and RAS/MEK/ERK (AZD6244) pathways synergistically inhibits rhabdomyosarcoma cell growth in vitro and in vivo.
                             
                            
                         | 
                        
                            
                                
                         | 
                        
                            
                         | 
                        
                            
                                 
                            
                         | 
                    
                
                    
                        
                            
                                Functional Consequences of the Macrophage Stimulating Protein 689C Inflammatory Bowel Disease Risk Allele.
                             
                            
                         | 
                        
                            
                                
                         | 
                        
                            
                         | 
                        
                            
                                 
                            
                         | 
                    
                
                    
                        
                            
                                Multimodal microvascular imaging reveals that selective inhibition of class I PI3K is sufficient to induce an antivascular response.
                             
                            
                         | 
                        
                            
                                
                         | 
                        
                            
                         | 
                        
                            
                                 
                            
                         | 
                    
                
                    
                        
                            
                                S49076 is a novel kinase inhibitor of MET, AXL and FGFR with strong preclinical activity alone and in association with bevacizumab.
                             
                            
                         | 
                        
                            
                                
                         | 
                        
                            
                         | 
                        
                            
                                 
                            
                         | 
                    
                
            
                | 
                    
                    View All
                 |